Health Care & Life Sciences » Medical Equipment & Supplies | Pathfinder Cell Therapy Inc.

Pathfinder Cell Therapy Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
344.00
73.00
114.00
54.00
-
Cost of Goods Sold (COGS) incl. D&A
92.00
26.00
50.00
37.00
3.00
Gross Income
252.00
47.00
64.00
17.00
3.00
SG&A Expense
2,751.00
3,665.00
2,124.00
1,616.00
1,116.00
EBIT
2,499.00
3,618.00
2,060.00
1,599.00
1,119.00
Unusual Expense
-
7,544.00
-
89.00
-
Interest Expense
12.00
108.00
96.00
195.00
275.00
Pretax Income
2,509.00
11,270.00
2,156.00
1,705.00
1,394.00
Income Tax
433.00
-
-
-
-
Consolidated Net Income
2,076.00
11,270.00
2,156.00
1,705.00
1,394.00
Net Income
2,076.00
11,270.00
2,156.00
1,705.00
1,394.00
Net Income After Extraordinaries
2,076.00
11,270.00
2,156.00
1,705.00
1,394.00
Net Income Available to Common
2,076.00
11,270.00
2,156.00
1,705.00
1,394.00
EPS (Basic)
0.02
0.02
0.00
0.00
0.00
Basic Shares Outstanding
109,439.00
526,105.00
667,162.00
667,162.00
667,161.00
EPS (Diluted)
0.02
0.02
0.00
0.00
0.00
Diluted Shares Outstanding
109,439.00
526,105.00
667,162.00
667,162.00
667,161.00
EBITDA
2,489.00
3,599.00
2,040.00
1,588.00
1,116.00
Non-Operating Interest Income
2.00
-
-
-
-

About Pathfinder Cell Therapy

View Profile
Address
12 Bow Street
Cambridge Massachusetts 02138
United States
Employees -
Website http://www.pathfindercelltherapy.com
Updated 07/08/2019
Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. It focuses on developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The company was founded by Richard L.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.